Anti Cancer Drug of EVEROLIMUS (RAD001) 159351-69-6

Basic Info

Model No.: 159351-69-6

Additional Info

Packaging: AS REQUIRED

Productivity: G,KGS,

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: COMMERCIAL PRODUCTION

Certificate: GMP/ISO

Product Description

We are supplying Everolimus,159351-69-6 purity NLT 99%, It is also named as RAD001, It is a derivative of the macrolide Rapamycin that acts as an immunosuppressant, mTOR inhibitor and anticancer agent. It targets the raptor mammalian target of rapamycin (mTORC1) Besides its immunosuppressive activity for the prevention of organ transplant rejection, everolimus exhibits antineoplastic activity and is currently used to treat renal cell cancer and other tumors

• Thera. Category:Anti-Cancer
• Cas No.:159351-69-6
• Synonym:42-O-(2-Hydroxyethyl)-rapamycin;Certica;RAD-001;SDZRAD;Rapamycin, 42-O-(2-hydroxyethyl)-;Everolimus;Certican;CERTICAN(R)
• Molecular Formula:C53H83NO14

• 
  
• Molecular Weight:958.232
• Specifications:Available on request
• Packing:Export worthy packing
• Material Safety Data Sheet:Available on request

Usage: Treats advanced kidney cancer. Also treats some types of pancreatic cancer, breast cancer, and brain cancer. Used with other medicines to keep your body from rejecting a transplanted kidney or liver.

A derivative of the macrolide Rapamycin (Cat. No. 1568-5, 50) that acts as an immunosuppressant, mTOR inhibitor and anticancer agent. It targets the raptor mammalian target of rapamycin (mTORC1).